Michael E Mullins Profile
Michael E Mullins

@MikeMullinsMD

Followers
995
Following
6K
Media
128
Statuses
998

EM physician, toxicologist, editor. Opinions are not medical advice.

Joined December 2016
Don't wanna be here? Send us removal request.
@MikeMullinsMD
Michael E Mullins
12 days
Not quite the "hair of the dog". What happens with your dog or cat affectionately licks you after you have applied topical minoxidil (Rogaine(r))? Colleagues from @WeillCornell & @ASPCA have the answers. https://t.co/cLCtZUhz74 @ASPCA_APCC @tandfmedicine
tandfonline.com
Topical minoxidil is a popular over-the-counter treatment for hair loss, but it is highly toxic to pets, particularly cats. Severe and sometimes fatal outcomes have occurred, yet public awareness r...
1
1
1
@MikeMullinsMD
Michael E Mullins
1 month
How could microplastics in the environment interact with toxic substances? What areas of research might we explore? Dr. Fadillah from @klik_uad & Dr. Long from Dongguan Univ. of Technology have some ideas. https://t.co/SqYr1BZrLF @tandfmedicine @tapna_inc @MENATOX @NIH_NIEHS
tandfonline.com
Published in Toxicology Communications (Vol. 9, No. 1, 2025)
0
0
3
@MikeMullinsMD
Michael E Mullins
2 months
Abstracts of the TAPNA 2025 Annual Scientific Meeting. https://t.co/EFfWXQpR24 Join @tapna_inc for another outstanding ASM in Cairns, Queensland 6-8 May 2026. @tandfmedicine
Tweet card summary image
tandfonline.com
Published in Toxicology Communications (Vol. 9, No. 1, 2025)
0
1
2
@acmtmedtox
American College of Medical Toxicology
2 months
Position Statement: ACMT Supports the Safe Use of #Acetaminophen in Pregnancy. Read our full statement here➡️ https://t.co/gtZ8zvxLmu @acog @MySMFM @AmerAcadPeds @SDBPeds
1
23
44
@MikeMullinsMD
Michael E Mullins
4 months
Colleagues at Central OH Poison Center & @nationwidekids use data from @PoisonCenters explore overdose effects of DXM-BUP combination to DXM alone. DXM-BUP had nearly 9 times the risk of seizure. Tachycardia was common. https://t.co/qPREtCHtE9 @tandfmedicine
tandfonline.com
Despite concerns regarding toxicity of the novel antidepressant, dextromethorphan-bupropion (DXM-BUP) in overdose, there is little information available. This study investigated characteristics of ...
0
0
3
@MikeMullinsMD
Michael E Mullins
4 months
Is your ED seeing more #fentanyl overdoses with sedation & bradycardia for hours after #naloxone? The cause is likely #xylazine or #medetomidine. Is it time for specific antidote? https://t.co/MrAtzGQypJ @tnpoisoncenter @WUSTL_EM @PoisonCenters @AACTinfo @acmtmedtox @NIDAnews
0
0
3
@MikeMullinsMD
Michael E Mullins
5 months
Trends in fomepizole administration for acetaminophen poisoning reported to United States poison centers, 2016–2024 Free access until August 31, 2025 from Am J Emerg Med. https://t.co/FHCQPsg3S5 @AriFilipMD @leonardjbRx @razorbacker66 @PoisonCenters
1
0
2
@MikeMullinsMD
Michael E Mullins
6 months
See the record number of abstracts from @menatox 2025! This meeting gets bigger and better each year. I look forward to the manuscripts arising from this meeting. https://t.co/kZQU1Fysnw @tandfmedicine @ZiadKazzi @WaleedAlsukaiti
tandfonline.com
Published in Toxicology Communications (Vol. 9, No. 1, 2025)
0
1
3
@MikeMullinsMD
Michael E Mullins
6 months
Snakebite research often uses the Snakebite Severity Score (SSS). Some elements are vital sign ranges for adults, but some studies include children & adolescents. How do we adapt the SSS for pediatric patients? https://t.co/1hA9wu10tp @tandfmedicine @ASFsnakebites
Tweet card summary image
tandfonline.com
Published in Toxicology Communications (Vol. 9, No. 1, 2025)
0
0
1
@MikeMullinsMD
Michael E Mullins
6 months
My good friend and colleague shares his thoughts in his review of a recently published book by @DrMakaryFDA https://t.co/L0RFFVtNNR @tandfmedicine
Tweet card summary image
tandfonline.com
Published in Toxicology Communications (Vol. 9, No. 1, 2025)
0
1
0
@MikeMullinsMD
Michael E Mullins
9 months
This is the companion to our 2023 paper "Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement" doi:10.1001/jamanetworkopen.2023.27739
0
0
3